FDA Clearance Tracker · P970008
TARGIS (T3) SYSTEM
Last checked: Nov 20, 2026Latest source record: Aug 22, 1997 (this decision)Source: openFDAMethods & limitations
Decided
Aug 22, 1997
Approved
Time to decision
179 days
Received Feb 24, 1997. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P970008
- Device name
- TARGIS (T3) SYSTEM
- Applicant
- Urologix, LLC
- Applicant location
- Plymouth, MN
- Received
- Feb 24, 1997
- Decided
- Aug 22, 1997
- Decision
- Approved
- Supplements
- 62 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
Approval for the T3(R) Targeted Transurethral Thermoablation System: Model 4000. This device is indicated to relieve symptoms associated with benign prostatic hyperplasia (BPH) and is indicated for men with prostatic lengths of 30 to 50 millimeters.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MEQ. The earliest in FDA's data is P950014, decided May 3, 1996.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Urologix, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.